Iovision (Iohexol)

Iohexol is a high‑density iodine‑containing compound. When administered, the iodine atoms absorb X‑rays more strongly than surrounding tissues, increasing attenuation and producing brighter images of blood vessels and organs, which allows radiologists to distinguish structures more clearly.

The dose of Iovision is individualized by the prescribing clinician based on the imaging study, patient weight, renal function, and the specific vascular territory to be examined. Only a qualified healthcare professional determines the appropriate volume and concentration.

The safety of Iohexol in pregnancy and lactation has not been established. It should be used only if the potential diagnostic benefit justifies the potential risk to the fetus or infant, and the decision should be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Iovision (Iohexol) is a non‑ionic, low‑osmolality iodinated contrast medium, offering a favorable safety profile compared with older high‑osmolality agents. It provides comparable image quality to other low‑osmolality agents such as iopamidol, while reducing the incidence of discomfort and adverse reactions.

Iovision should be stored at controlled room temperature, below 25 °C, in its original sealed container. Protect the solution from light, moisture and freezing. Inspect the vial for particulate matter before use and discard if the seal is compromised.

Iovision is supplied as a sterile solution for intra‑arterial, intravenous or intrathecal injection. The administration technique depends on the imaging procedure; it is typically injected as a bolus or through a power injector under the supervision of trained radiology personnel.

Serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute kidney injury, and rare cardiovascular events like arrhythmias or pulmonary edema. Patients with known iodine allergy, impaired renal function, or severe thyroid disease require careful assessment before use.

Iovision is contraindicated in patients with a documented hypersensitivity to iodinated contrast media, those with uncontrolled hyperthyroidism, and individuals with severe renal impairment where alternative imaging is feasible. Clinicians must evaluate each patient’s medical history before administration.